Browsing by Author "Arenas Mirave, Juan Ignacio"
Now showing items 1-4 of 4
-
Effect of resveratrol on alcohol-induced mortality and liver lesions in mice
Bujanda Fernández de Pierola, Luis ; García Barcina, María; Gutiérrez de Juan, Virginia; Bidaurrazaga Van Dierdonck, Joseba; Fernández de Luco, Marian; Gutiérrez Stampa, María Angeles; Larzabal, Mikel; Hijona Muruamendiaraz, Elizabeth; Sarasqueta, Cristina; Echenique Elizondo, Miguel; Arenas Mirave, Juan Ignacio (BioMed Central, 2006-11-14)Background Resveratrol is a polyphenol with important antiinflammatory and antioxidant properties. We investigated the effect of resveratrol on alcohol-induced mortality and liver lesions in mice. Methods Mice were ... -
Inflammatory Mediators of Hepatic Steatosis
Hijona Muruamendiaraz, Elizabeth; Hijona Muruamendiaraz, Lander; Arenas Mirave, Juan Ignacio; Bujanda Fernández de Pierola, Luis (Hindawi Publishing Corporation, 2010)Nonalcoholic fatty liver disease (NAFLD) is rapidly becoming a world-wide public health problem. NAFLD represents a spectrum of disease ranging from “simple steatosis”, which is considered relatively benign, to nonalcoholic ... -
Pravastatin inhibits cell proliferation and increased MAT1A expression in hepatocarcinoma cells and in vivo models
Hijona Muruamendiaraz, Elizabeth; Bañales Asurmendi, Jesús María ; Hijona Muruamendiaraz, Lander; Medina, Juan F.; Arenas Mirave, Juan Ignacio; Herreros Villanueva, Marta; Aldazabal, Pablo; Bujanda Fernández de Pierola, Luis (BioMed Central, 2012-02-21)Background: Statins may have therapeutic effects on hepatocarcinoma (HCC). This type of disorder is the most common malignant primary tumour in the liver. Our objective was to determine whether pravastatin had a therapeutic ... -
Resveratrol inhibits nonalcoholic fatty liver disease in rats
Bujanda Fernández de Pierola, Luis ; Hijona Muruamendiaraz, Elizabeth; Larzabal, Mikel; Beraza, Marta; Aldazabal, Pablo; García Urkia, Nerea; Sarasqueta, Cristina; Cosme Jiménez, Ángel; Irastorza, Belen; González, Alberto; Arenas Mirave, Juan Ignacio (BioMed Central, 2008-09-09)Background: The prevalence of nonalcoholic fatty liver disease (NAFLD) is high. NAFLD is linked to obesity, diabetes mellitus, and hypertriglyceridemia. Approximately 20% of patients with NAFLD will eventually develop ...